This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Related letter  • Similar articles in JAMA  Topic Collections  • Oncology  • Breast Cancer  • Colon Cancer  • Women's Health  • Women's Health, Other  • Drug Therapy  • Drug Therapy, Other  • Gastroenterology  • Gastrointestinal Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Dr Odell suggests that an increase in colorectal cancer incidence in women should be expected now that use of postmenopausal hormone therapy has declined. Although we do not share his opinion that this is the most important implication of the postintervention report from the WHI, we agree that vigilance in this area is warranted.

We reported in the WHI randomized trial that 44% fewer invasive colorectal cancers were diagnosed in participants in the conjugated equine estrogen plus medroxyprogesterone acetate group compared with those in the placebo group.¹ However, we also noted that the colorectal cancers were found at higher stage, and a role for delayed assessment of clinical symptoms could not be excluded as a factor influencing this finding.¹ In contrast, the incidence of invasive breast cancer was significantly increased by combined hormone therapy in the same trial²; in the present study, although more breast cancers continue . . . [Full Text of this Article]

Rowan T. Chlebowski, MD, PhD
rchlebowski@gmail.com
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
Torrance, California

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin
Gerardo Heiss, Robert Wallace, Garnet L. Anderson, Aaron Aragaki, Shirley A. A. Beresford, Robert Brzyski, Rowan T. Chlebowski, Margery Gass, Andrea LaCroix, JoAnn E. Manson, Ross L. Prentice, Jacques Rossouw, Marcia L. Stefanick, and for the WHI Investigators
JAMA. 2008;299(9):1036-1045.
ABSTRACT | FULL TEXT  

RELATED LETTER

Colorectal Cancer in Women After Stopping Postmenopausal Hormone Therapy
Timothy W. Odell
JAMA. 2008;299(23):2744.
EXTRACT | FULL TEXT